Amphastar Pharmaceuticals, Inc. AMPH

26.13 (0.14) (0.53%) as of 25 Sep
Market cap
$1.1B
P/E
15.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
285.25 224.08 259.24 178.20 139.11 109.68 89.52 93.32 72.38 74.27
Receivables
160.73 138.04 115.47 88.98 78.93 66.39 45.69 52.21 42.03 26.80
Inventory
176.89 153.74 105.83 103.58 92.81 96.83 110.50 69.32 63.61 79.75
Total current assets
636.02 534.07 489.60 378.32 318.12 279.68 255.24 220.34 187.78 184.10
Property, Plant, Equpment (Net)
310.57 297.35 282.75 238.27 244.24 260.06 233.86 210.42 180.55 152.94
Long-Term Investments
— 11.00 15.21 2.41 3.99 — — — — —
Goodwill and Intangible Assets (Total)
565.97 590.66 613.30 37.30 38.87 40.62 41.15 42.27 45.14 50.31
Long Term Assets (Tax, Deferred)
42.46 71.12 53.25 38.53 22.40 24.98 25.87 30.62 28.95 31.00
Long-term assets (Other)
31.14 25.99 25.91 20.86 16.67 5.25 11.16 9.92 8.66 9.39
Total non-current assets
993.28 1,043.40 1,023.31 363.67 353.41 351.55 331.73 293.22 263.29 243.64
Total Assets
1,629.30 1,577.47 1,512.91 741.99 671.53 631.24 586.97 513.56 451.07 427.74
Accounts Payable
148.35 157.06 93.37 84.24 89.55 95.50 77.05 87.42 57.56 47.55
Accrued Expenses
— 157.06 126.09 — — — — — — —
Current Part of Debt
1.64 0.23 0.44 3.05 2.20 12.26 7.74 18.23 6.31 5.37
Current Part of Taxes to Pay
0.24 9.66 1.61 4.57 9.08 1.08 2.04 1.19 3.33 7.71
Total current liabilities
158.16 173.76 225.41 94.86 103.81 112.20 90.01 106.83 67.19 60.62
Long Term Debt (Total)
608.75 601.63 589.58 72.84 74.78 34.19 39.39 31.98 40.84 32.36
Long Term Tax Liability (Deferred)
— — — 0.14 0.53 0.74 0.87 1.03 1.36 1.46
Non-current Liabilities (Other)
35.91 27.90 28.78 21.79 22.18 17.92 12.86 9.36 7.94 4.06
Total non-current liabilities
682.34 671.41 648.08 118.47 122.20 70.31 69.43 42.37 50.14 37.87
Total liabilities
840.49 845.17 873.49 213.33 226.01 182.51 159.44 149.20 117.34 98.48
Additional Paid In Capital
535.38 505.40 486.06 455.08 422.42 410.06 367.31 344.43 313.89 283.12
Common Stock (Net)
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Retained Earnings
666.88 568.79 409.27 271.72 180.34 117.77 116.37 67.49 72.64 70.86
Treasury Stock
408.15 332.71 247.43 189.52 150.48 121.81 97.63 75.48 50.70 20.03
Common Equity (Total)
788.80 732.30 639.42 528.66 445.52 448.72 427.53 364.36 333.74 329.26
Shareholders Equity (Total)
788.81 732.30 639.42 528.66 445.52 448.72 427.53 364.36 333.74 329.26
Shareholders Equity and Liabilities (Total)
1,629.30 1,577.47 1,512.91 741.99 671.53 631.24 586.97 513.56 451.07 427.74
Shares (Common)
45.65 47.62 48.07 48.11 47.71 47.50 46.58 46.63 46.62 46.25
Shareholders Equity (Tangible)
222.84 141.64 26.13 491.36 406.65 408.11 386.38 322.09 288.60 278.95
Net Debt
325.14 377.78 330.77 (102.31) (62.13) (63.23) (42.38) (43.11) (25.23) (36.55)
Total Debt
610.39 601.86 590.02 75.89 76.98 46.45 47.14 50.21 47.16 37.72

Fold the line items

In millions of $ except per-share values · columns are period end dates